Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Venetoclax Plus Dexamethasone As First-Line Treatment for t(11; 14) Light-Chain Amyloidosis: Preliminary Result of a Phase II Prospective, Multicenter, Single-Arm Study

Kaini Shen, Ai Guan, Yu Wu, Chunyan Sun, Liye Zhong, Jun Luo, Jian Li

Blood (2024) 144 (Supplement 1): 893.

https://doi.org/10.1182/blood-2024-204346

Published: 2024

Journal Articles

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Blood (2024) 144 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2024-204513

Published: 2024

Journal Articles

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Wenjing Wang, Jing Li, Mengyuan Li, Xiao He, LI Bao, Xiaoqiong Tang, Hua Xue, Jianmei Xu, Liye Zhong, Peng Liu

Blood (2024) 144 (Supplement 1): 5159.

https://doi.org/10.1182/blood-2024-207888

Published: 2024

Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Blood (2023) 142 (Supplement 1): 4754.

https://doi.org/10.1182/blood-2023-180736

Published: 2023

Journal Articles

Immune Checkpoint Expression Patterns on T Cell Subsets in Light-Chain Amyloidosis: VISTA, PD-1, and Tigit As Potential Therapeutic Targets

Jinghua Wang, Yujie Zhao, Yujie Liao, Yangqiu Li, Liye Zhong, Shaohua Chen

Blood (2023) 142 (Supplement 1): 6588.

https://doi.org/10.1182/blood-2023-189544

Published: 2023

Journal Articles

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Blood (2022) 140 (Supplement 1): 3609–3611.

https://doi.org/10.1182/blood-2022-158675

Published: 2022

Journal Articles

Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice

Blood (2021) 138 (Supplement 1): 2718.

https://doi.org/10.1182/blood-2021-149058

Published: 2021

Journal Articles

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

Gang An, MD PhD, Daobin Zhou, MD PhD, Weili Zhao, MD PhD, Keshu Zhou, MD PhD, Jianyong Li, MD PhD, Jianfeng Zhou, MD PhD, Liping Xie, MD PhD, Jie Jin, MD PhD, Liye Zhong, MD PhD, Lingzhi Yan, MD PhD, Haiyi Guo, MD, Chenmu Du, MD, Jane Huang, MD, William Novotny, MD, Jinhua Zhong, PhD, Lugui Qiu, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-136783

Published: 2020

Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-136842

Published: 2020

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia

Xiaomei Chen, Jianyu Weng, Yulian Wang, Chengxin Deng, Chengwei Luo, Pengjun Liao, Minming Li, Xin Huang, Peilong Lai, Lisi Huang, Zhi Cao, Changchun Wan, Liye Zhong, Suijing Wu, Zesheng Lu, Xiaoli Zou, Xin Du

Blood (2015) 126 (23): 4897.

https://doi.org/10.1182/blood.V126.23.4897.4897

Published: 2015

Journal Articles

Mucin 20 (MUC20) Modulates Proteasome Assembly Chaperones through the c-MET Pathway and Is a Biomarker of Proteasome Inhibitor Sensitivity in Myeloma

Huihan Wang, MD, PhD, Veerabhadran Baladandayuthapani, PhD, Heather Yan Lin, PhD, Xiaobin Wang, MD, Bingzong Li, MD, PhD, Xing-Ding Zhang, PhD, Isere Kuiatse, PhD, Hua Wang, PhD, Dongmin Gu, MD, PhD, Liye Zhong, PhD, Wencai Ma, PhD, Richard E. Davis, MD, Robert Z. Orlowski, MD, PhD

Blood (2014) 124 (21): 274.

https://doi.org/10.1182/blood.V124.21.274.274

Published: 2014

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Change of the Notch1 Expression Level in Lymphoid Malignancies.

Haitao Zheng, Lijian Yang, Shao-Hua Chen, Liye Zhong, Yangqiu Li

Blood (2009) 114 (22): 4425.

https://doi.org/10.1182/blood.V114.22.4425.4425

Published: 2009

Journal Articles

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

SuXia Geng, MD, Xin Du, PhD, Yangqiu Li, PhD, Jianyu Weng, MD, Liye Zhong, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD

Blood (2009) 114 (22): 4833.

https://doi.org/10.1182/blood.V114.22.4833.4833

Published: 2009

Journal Articles

Differential Protein Expression of Serum in Patients with RAEB Myelodysplastic Syndromes.

Liye Zhong, Tianhao Liu, Yangqiu Li, PhD, Suxia Geng, Zesheng Lu, Jianyu Weng, Suijing Wu, Xin Du, PhD

Blood (2009) 114 (22): 4845.

https://doi.org/10.1182/blood.V114.22.4845.4845

Published: 2009

Journal Articles

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

SuXia Geng, MD, Xin Du, PhD/MD, Jianyu Weng, MD, Liye Zhong, MD, Rong Guo, PhD, Zesheng Lu, MD, Suijing Wu, MD

Blood (2009) 114 (22): 4132.

https://doi.org/10.1182/blood.V114.22.4132.4132

Published: 2009

Journal Articles

Serum Proteome Profiling Detects Myelodysplastic Syndromes and Different Expression of Fibrinogen Between RAEB and RCMD

Liye Zhong, MD, TianHao Liu, MD, SuXia Geng, MD, Zesheng Lu, MD, Jianyu Weng, MD, Xin Du, PhD/MD

Blood (2008) 112 (11): 5082.

https://doi.org/10.1182/blood.V112.11.5082.5082

Published: 2008

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

Journal Articles

Analysis of the T-Cell Receptor Repertoire in the Study of Immunological Abnormalities in Myelodysplastic Syndromes (MDS).

Xin Du, PhD, Yangqiu Li, Ph.D, Jianyu Weng, MD, Liye Zhong, MD, Shaohua Chen, MD, Lijian Yang, MD, Zesheng Lu, MD

Blood (2005) 106 (11): 4921.

https://doi.org/10.1182/blood.V106.11.4921.4921

Published: 2005

NARROW

Venetoclax Plus Dexamethasone As First-Line Treatment for t(11; 14) Light-Chain Amyloidosis: Preliminary Result of a Phase II Prospective, Multicenter, Single-Arm Study

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Comparison of Ixazomib, Lenalidomide Plus Dexamethasone (IRd) and Bortezomib, Lenalidomide Plus Dexamethasone (VRd) in Newly Diagnosed Multiple Myeloma in China

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Immune Checkpoint Expression Patterns on T Cell Subsets in Light-Chain Amyloidosis: VISTA, PD-1, and Tigit As Potential Therapeutic Targets

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia

Mucin 20 (MUC20) Modulates Proteasome Assembly Chaperones through the c-MET Pathway and Is a Biomarker of Proteasome Inhibitor Sensitivity in Myeloma

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Change of the Notch1 Expression Level in Lymphoid Malignancies.

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

Differential Protein Expression of Serum in Patients with RAEB Myelodysplastic Syndromes.

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

Serum Proteome Profiling Detects Myelodysplastic Syndromes and Different Expression of Fibrinogen Between RAEB and RCMD

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Analysis of the T-Cell Receptor Repertoire in the Study of Immunological Abnormalities in Myelodysplastic Syndromes (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only